ATE41742T1 - Verfahren zur herstellung von gereinigten bakteriellen antigenischen kapselpolysacchariden, die erhaltenen produkte und ihre verwendung. - Google Patents

Verfahren zur herstellung von gereinigten bakteriellen antigenischen kapselpolysacchariden, die erhaltenen produkte und ihre verwendung.

Info

Publication number
ATE41742T1
ATE41742T1 AT82107154T AT82107154T ATE41742T1 AT E41742 T1 ATE41742 T1 AT E41742T1 AT 82107154 T AT82107154 T AT 82107154T AT 82107154 T AT82107154 T AT 82107154T AT E41742 T1 ATE41742 T1 AT E41742T1
Authority
AT
Austria
Prior art keywords
polysaccharids
capsule
processes
production
purified bacterial
Prior art date
Application number
AT82107154T
Other languages
English (en)
Inventor
Robert W Liveyns
Daniel Gilles
Marcel Arickx
Original Assignee
Smith Kline Rit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline Rit filed Critical Smith Kline Rit
Application granted granted Critical
Publication of ATE41742T1 publication Critical patent/ATE41742T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT82107154T 1981-08-14 1982-08-07 Verfahren zur herstellung von gereinigten bakteriellen antigenischen kapselpolysacchariden, die erhaltenen produkte und ihre verwendung. ATE41742T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE0/205681A BE889979A (fr) 1981-08-14 1981-08-14 Procede de preparation de polysaccharides bacteriens capsulaires antigeniques purifies, produits obtenus et leur utilisation
EP82107154A EP0072513B1 (de) 1981-08-14 1982-08-07 Verfahren zur Herstellung von gereinigten Bakteriellen antigenischen Kapselpolysacchariden, die erhaltenen Produkte und ihre Verwendung

Publications (1)

Publication Number Publication Date
ATE41742T1 true ATE41742T1 (de) 1989-04-15

Family

ID=3843449

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82107154T ATE41742T1 (de) 1981-08-14 1982-08-07 Verfahren zur herstellung von gereinigten bakteriellen antigenischen kapselpolysacchariden, die erhaltenen produkte und ihre verwendung.

Country Status (4)

Country Link
EP (1) EP0072513B1 (de)
AT (1) ATE41742T1 (de)
BE (1) BE889979A (de)
DE (1) DE3279579D1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0145359B1 (de) * 1983-11-21 1991-01-16 The Wellcome Foundation Limited Komplexe, Verfahren zu ihrer Herstellung und dieselben enthaltende Formulierungen
US4686102A (en) * 1984-04-12 1987-08-11 American Cyanamid Company Multivalent pneumococcal vaccine and preparation thereof
US4877613A (en) * 1987-08-05 1989-10-31 Biotech Connections, Inc. Process for preparing veterinary acellular vaccines against gram-negative nonenteric pathogenic bacilli
DE69012682T2 (de) * 1989-06-12 1995-04-06 Merck & Co Inc Verfahren zur Entfernung von bakteriellen Endotoxinen aus gram-negativen Polysacchariden.
US5714354A (en) * 1995-06-06 1998-02-03 American Home Products Corporation Alcohol-free pneumococcal polysaccharide purification process
ATE280834T1 (de) * 1996-02-14 2004-11-15 Merck & Co Inc Verfahren zur präzipitation von polysacchariden
US6410025B1 (en) 1996-02-14 2002-06-25 Merck & Co., Inc. Polysaccharide precipitation process
TR200102739T2 (tr) 1999-03-19 2001-12-21 Smithkline Beecham Biologicals S.A. Aşı
GB9909077D0 (en) 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
GB0408978D0 (en) 2004-04-22 2004-05-26 Chiron Srl Meningococcal fermentation for preparing conjugate vaccines
EP1866342B1 (de) * 2005-04-08 2018-11-21 Wyeth LLC Abtrennung von kontaminanten aus streptococcus-pneumoniae-polysaccharid durch ph-beeinflussung
ATE548051T1 (de) 2005-04-08 2012-03-15 Wyeth Llc Multivalente pneumokokken- polysaccharidproteinkonjugatzusammensetzung
GB0522303D0 (en) 2005-11-01 2005-12-07 Chiron Srl Culture method
DK1973564T3 (da) 2005-12-22 2017-01-16 Glaxosmithkline Biologicals Sa Vaccine omfattende streptococcus pneumoniae-kapselpolysaccharidkonjugat
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
WO2008104811A1 (en) * 2007-02-28 2008-09-04 Lipoxen Technologies Limited Reduction of endotoxin in polysialic acids
EP2155244B1 (de) * 2007-04-23 2017-03-22 Serum Institute of India Private Limited Antigene polysaccharide und verfahren zu ihrer herstellung
EA201391788A1 (ru) 2007-06-26 2014-08-29 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
GB0818453D0 (en) 2008-10-08 2008-11-12 Novartis Ag Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
CN102099379B (zh) * 2008-06-19 2013-12-11 本德尔分析控股有限公司 用于从生物聚合物材料中去除杂质的方法
ES2666698T3 (es) 2008-12-18 2018-05-07 Wyeth Llc Procedimiento de control del peso molecular del polisacárido del serotipo 19A de Streptococcus pneumoniae
HUE046859T2 (hu) 2008-12-18 2020-03-30 Wyeth Llc Eljárás Streptococcus pneumoniae poliszacharid molekulatömegének szabályozására szén alkalmazásával
CN106460062A (zh) 2014-05-05 2017-02-22 美敦力公司 用于scd、crt、crt‑d或sca治疗识别和/或选择的方法和组合物
EP3034516A1 (de) 2014-12-19 2016-06-22 Novartis AG Reinigung von Streptokokkenkapselpolysaccharid
US11191822B2 (en) 2016-06-22 2021-12-07 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Pneumococcal polysaccharide-protein conjugate composition
EP3269385A1 (de) 2016-07-12 2018-01-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Pneumokokken-polysaccharid-proteinkonjugatzusammensetzung
EP3551668A1 (de) 2016-12-06 2019-10-16 GlaxoSmithKline Biologicals S.A. Reinigungsverfahren für kaspelpolysaccharid
EP3900739A1 (de) 2020-04-21 2021-10-27 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Synthetische streptococcus-pneumoniae-saccharid-konjugate zum konservierten membranprotein
EP3919076A1 (de) 2020-06-02 2021-12-08 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Synthetische oligosaccharidimpfstoffe gegen streptococcus pneumoniae mit mikropartikel-adjuvans-formulierungen

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3636192A (en) * 1970-01-13 1972-01-18 Us Army Meningococcal polysaccharide vaccines
US3978209A (en) * 1975-03-24 1976-08-31 Merck & Co., Inc. Endotoxin free meningococcus polysaccharides
FR2388563A1 (fr) * 1977-04-29 1978-11-24 Fabre Sa Pierre Vaccins acellulaires perfectionnes contenant des polysaccharides capsulaires
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
US4134214A (en) * 1977-08-05 1979-01-16 Merck & Co., Inc. Freeze-drying process for the preparation of meningococcus vaccine without degradation of potency
DE2748132A1 (de) * 1977-10-27 1979-05-03 Behringwerke Ag Stabilisator fuer polysaccharid
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
CA1115210A (en) * 1977-11-28 1981-12-29 Dennis J. Carlo Pneumococcal vaccine
US4235994A (en) * 1978-06-26 1980-11-25 Merck & Co., Inc. High molecular weight meningococcal group C vaccine and method for preparation thereof
US4264764A (en) * 1979-01-12 1981-04-28 Merck & Co., Inc. Meningitis vaccine
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
US4242501A (en) * 1979-08-08 1980-12-30 American Cyanamid Company Purification of pneumococcal capsular polysaccharides
PT72812B (en) * 1980-04-14 1983-02-16 Merck & Co Inc Process for preparing group b streptococcal capsular polysccha-rides
US4407949A (en) * 1980-09-22 1983-10-04 Merck & Co., Inc. Meningitis vaccine

Also Published As

Publication number Publication date
EP0072513A2 (de) 1983-02-23
EP0072513A3 (en) 1986-02-19
DE3279579D1 (en) 1989-05-03
EP0072513B1 (de) 1989-03-29
BE889979A (fr) 1982-02-15

Similar Documents

Publication Publication Date Title
ATE41742T1 (de) Verfahren zur herstellung von gereinigten bakteriellen antigenischen kapselpolysacchariden, die erhaltenen produkte und ihre verwendung.
DE69630837D1 (de) Verfahren zur Herstellung einer wässrigen Suspension von Teilchen, die ein im wesentlichen lichtunempfindliches Silbersalz einer organischen Carbonsäure enthalten, für die Herstellung (photo)thermographischen Materialien
ATE13414T1 (de) Verfahren zur herstellung von faellungskieselsaeuren.
IT8120947A0 (it) Processo per la produzione di microcapsule.
DE3766160D1 (de) Hochreines titan und verfahren zu seiner herstellung.
DE3782979T4 (de) Verfahren zur Herstellung eines verglasten Produkts.
ATE66678T1 (de) Verfahren zur herstellung von makrolidderivaten.
HK59595A (en) Process for producing toner by suspension polymerzation method.
DE3786933T2 (de) Verfahren zur Herstellung von mono-dispergierten Teilchen.
DE59007360D1 (de) Verfahren zur hydrothermalen herstellung von kaliumsilikatlösungen.
IT8122657A0 (it) Processo per la produzione di acetaldeide da etanolo.
DE3871336D1 (de) Kolloidale dispersion einer cer iv-verbindung in waessrigem medium und verfahren zu dessen herstellung.
DE3780760T2 (de) Verfahren zur herstellung von silikonmikrokapseln, geliert durch eine michael-additionsreaktion.
FR2506129B1 (fr) Procede pour la fabrication de produits de lait caille consistants
NL7604298A (nl) Werkwijze en inrichting voor de continue vervaar- diging van gestandaardiseerde melk, evenals ge- standaardiseerde melk vervaardigd volgens de werkwijze.
DE59008459D1 (de) Verfahren zur Herstellung von Vinylacetat.
NL192616B (nl) Werkwijze ter bereiding van 1,3,5-trihydroxybenzeen.
RO84911A (ro) Procedeu pentru prepararea unor 1,1-alcandioli carboxilati
IT7921831A0 (it) Processo per la produzione microbiologica di chetoni.
ATE21508T1 (de) Verfahren zur herstellung von alphahaloalkylamiden.
DE3870824D1 (de) Verfahren zur herstellung von 1:2-metallkomplexazofarbstoffen.
HUT34517A (en) Process for the production of light-sensitive silver-halogenide emulsion having improved physical,chemical and photographic properties,by using water-soluble cyclodextrin-polymers
ATE82566T1 (de) Verfahren zur herstellung von alpha-(1methylethyl)-3,4-dimethoxybenzeneacetonitril.
IT8202905A0 (it) Procedimento per la produzione dicorpi ottenuti per formatura da polilaurinlattame nonche' corpi da formatura cosi' ottenuti.
ATE13421T1 (de) Verfahren zur herstellung von 4-aminobutters|ureamide.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee